Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(22%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
3
33%
Ph not_applicable
2
22%
Ph phase_4
3
33%
Ph phase_3
1
11%

Phase Distribution

3

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1
Not yet recruiting1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (33.3%)
Phase 31 (11.1%)
Phase 43 (33.3%)
N/A2 (22.2%)

Trials by Status

terminated111%
completed556%
not_yet_recruiting111%
active_not_recruiting111%
recruiting111%

Recent Activity

2 active trials
Showing 5 of 9
active_not_recruitingphase_3

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

NCT05047172
recruitingnot_applicable

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD

NCT06714526
not_yet_recruitingphase_4

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

NCT06763744
terminatedphase_4

Anticoagulant Treatments and Percutaneous Coronary Angioplasty

NCT00669149
completednot_applicable

PACT (Platelet Activity After Clopidogrel Termination)

NCT00619073
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05047172Phase 3

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Active Not Recruiting
NCT06714526Not Applicable

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD

Recruiting
NCT06763744Phase 4

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

Not Yet Recruiting
NCT00669149Phase 4

Anticoagulant Treatments and Percutaneous Coronary Angioplasty

Terminated
NCT00619073Not Applicable

PACT (Platelet Activity After Clopidogrel Termination)

Completed
NCT01823510Phase 4

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Completed
NCT01526122Phase 1

Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration

Completed
NCT01657071Phase 1

Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects

Completed
NCT01422109Phase 1

Comparative Pharmacokinetics of YH14659

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9